Cargando…

Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients

Nontuberculous mycobacteria (NTM) and many fungal species (spp.) are commonly associated with opportunistic infections (OPIs) in immunocompromised individuals. Moreover, occurrence of concomitant infection by NTM (mainly spp. of Mycobacterium avium complex and Mycobacterium abscessus complex) and fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Joao, Ines, Bujdáková, Helena, Jordao, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693372/
https://www.ncbi.nlm.nih.gov/pubmed/33147819
http://dx.doi.org/10.3390/antibiotics9110771
_version_ 1783614728877113344
author Joao, Ines
Bujdáková, Helena
Jordao, Luisa
author_facet Joao, Ines
Bujdáková, Helena
Jordao, Luisa
author_sort Joao, Ines
collection PubMed
description Nontuberculous mycobacteria (NTM) and many fungal species (spp.) are commonly associated with opportunistic infections (OPIs) in immunocompromised individuals. Moreover, occurrence of concomitant infection by NTM (mainly spp. of Mycobacterium avium complex and Mycobacterium abscessus complex) and fungal spp. (mainly, Aspergillus fumigatus, Histoplasma capsulatum and Cryptococcus neoformans) is very challenging and is associated with poor patient prognosis. The most frequent clinical symptoms for coinfection and infection by single agents (fungi or NTM) are similar. For this reason, the accurate identification of the aetiological agent(s) is crucial to select the best treatment approach. Despite the significance of this topic it has not been sufficiently addressed in the literature. This review aims at summarizing case reports and studies on NTM and fungi coinfection during the last 20 years. In addition, it briefly characterizes OPIs and coinfection, describes key features of opportunistic pathogens (e.g., NTM and fungi) and human host predisposing conditions to OPIs onset and outcome. The review could interest a wide spectrum of audiences, including medical doctors and scientists, to improve awareness of these infections, leading to early identification in clinical settings and increasing research in the field. Improved diagnosis and availability of therapeutic options might contribute to improve the prognosis of patients’ survival.
format Online
Article
Text
id pubmed-7693372
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76933722020-11-28 Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients Joao, Ines Bujdáková, Helena Jordao, Luisa Antibiotics (Basel) Review Nontuberculous mycobacteria (NTM) and many fungal species (spp.) are commonly associated with opportunistic infections (OPIs) in immunocompromised individuals. Moreover, occurrence of concomitant infection by NTM (mainly spp. of Mycobacterium avium complex and Mycobacterium abscessus complex) and fungal spp. (mainly, Aspergillus fumigatus, Histoplasma capsulatum and Cryptococcus neoformans) is very challenging and is associated with poor patient prognosis. The most frequent clinical symptoms for coinfection and infection by single agents (fungi or NTM) are similar. For this reason, the accurate identification of the aetiological agent(s) is crucial to select the best treatment approach. Despite the significance of this topic it has not been sufficiently addressed in the literature. This review aims at summarizing case reports and studies on NTM and fungi coinfection during the last 20 years. In addition, it briefly characterizes OPIs and coinfection, describes key features of opportunistic pathogens (e.g., NTM and fungi) and human host predisposing conditions to OPIs onset and outcome. The review could interest a wide spectrum of audiences, including medical doctors and scientists, to improve awareness of these infections, leading to early identification in clinical settings and increasing research in the field. Improved diagnosis and availability of therapeutic options might contribute to improve the prognosis of patients’ survival. MDPI 2020-11-02 /pmc/articles/PMC7693372/ /pubmed/33147819 http://dx.doi.org/10.3390/antibiotics9110771 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Joao, Ines
Bujdáková, Helena
Jordao, Luisa
Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients
title Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients
title_full Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients
title_fullStr Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients
title_full_unstemmed Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients
title_short Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients
title_sort opportunist coinfections by nontuberculous mycobacteria and fungi in immunocompromised patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693372/
https://www.ncbi.nlm.nih.gov/pubmed/33147819
http://dx.doi.org/10.3390/antibiotics9110771
work_keys_str_mv AT joaoines opportunistcoinfectionsbynontuberculousmycobacteriaandfungiinimmunocompromisedpatients
AT bujdakovahelena opportunistcoinfectionsbynontuberculousmycobacteriaandfungiinimmunocompromisedpatients
AT jordaoluisa opportunistcoinfectionsbynontuberculousmycobacteriaandfungiinimmunocompromisedpatients